NCT03261323

Brief Summary

The purpose of this study is to:

  1. 1.Evaluate whether immediate or delayed reconstruction should be offered for breast reconstruction candidates with higher risk for surgical complications by comparing complications, quality of life, and hospital costs
  2. 2.Determine the efficacy of risk reduction strategies for breast reconstruction patients with higher risk for surgical complications

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2019

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 25, 2017

Completed
1.8 years until next milestone

Study Start

First participant enrolled

May 31, 2019

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

May 20, 2022

Status Verified

May 1, 2022

Enrollment Period

3.1 years

First QC Date

July 19, 2017

Last Update Submit

May 16, 2022

Conditions

Keywords

Breast ReconstructionMastectomy

Outcome Measures

Primary Outcomes (1)

  • optimal timing of reconstruction in patients at a higher risk for developing breast reconstruction surgical complications

    Proportion of patients preferring delayed reconstruction.

    Until 1 year post breast reconstruction

Secondary Outcomes (5)

  • Major complications

    Until 1 year post breast reconstruction

  • Minor complications

    Until 1 year post breast reconstruction

  • Number of revision surgeries

    Until 1 year post breast reconstruction

  • Hospital cost of the complete reconstruction treatment

    Until 1 year post breast reconstruction

  • Change in patient satisfaction

    Until 1 year post breast reconstruction

Other Outcomes (1)

  • Aesthetic evaluation

    Until 1 year post breast reconstruction

Study Arms (2)

Immediate breast reconstruction

ACTIVE COMPARATOR

The surgical schedule will follow unaltered standard protocol for immediate reconstruction right after the patient's mastectomy. Patients will complete a quality of life questionnaire (Breast-Q) both pre-operatively and at different time points during the follow up. The patient's chart will be followed from the mastectomy surgery onwards until 1 year post-final reconstructive surgery for determining complications and hospital costs.

Procedure: Immediate Breast ReconstructionOther: Breast-Q questionnaire

Delayed breast reconstruction

EXPERIMENTAL

Patients will start the reconstruction process after cancer therapy has been completed. Patients will be directed to smoking cessation and weight loss resources such as the Bariatric Institute to most directly facilitate risk reduction goals. Risk scores will be assessed at a plastic surgery appointment every 3 months. Reconstruction will proceed after the cancer treatment has been completed, according to individual patient evaluation. Patients will complete a quality of life questionnaire (Breast-Q) both pre-operatively and after the final reconstruction surgery. The patient's chart will be followed from the mastectomy surgery onwards until 1 year post-final reconstructive surgery for determining complications and hospital costs.

Procedure: Delayed Breast ReconstructionOther: Breast-Q questionnaire

Interventions

Only implant based surgeries will be considered in this study. The patient will be followed for at least 1 year after the last reconstruction surgery. Reconstruction will be attempted immediately after mastectomy.

Immediate breast reconstruction

Risk reduction strategies on smoking, weight, and chronic disease control will be offered. The individual risk will be recalculated every three months. Delayed breast reconstruction will be offered when core cancer therapies (mastectomy, chemotherapy and radiation) are complete. Only implant based surgeries will be considered in this study. The patient will be followed for at least 1 year after the last reconstruction surgery.

Delayed breast reconstruction

Developed out of Memorial Sloan-Kettering Institute for Cancer Research, this questionnaire is designed to create a patient-reported outcome measure to provide quantifiable information about the impact and effectiveness of breast surgery. In this study it will be used for quality of life assessment

Delayed breast reconstructionImmediate breast reconstruction

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must have histologically or cytologically confirmed breast cancer or indication for prophylactic mastectomy.
  • Subjects must be breast reconstruction candidates using implant based breast reconstruction.
  • Subjects must have a pre-operative risk \>20% complication prediction from the Breast Reconstruction Risk Assessment (BRA) Score for implant-based breast reconstruction candidates
  • Subjects must have the ability to understand and the willingness to sign a written informed consent document.

You may not qualify if:

  • Prior breast cancer surgical treatment
  • Prior breast reconstruction
  • Inability to provide written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic, Case Comprehensive Cancer Center

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Risal Djohan, MD

    Cleveland Clinic, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2017

First Posted

August 25, 2017

Study Start

May 31, 2019

Primary Completion

July 1, 2022

Study Completion

July 1, 2022

Last Updated

May 20, 2022

Record last verified: 2022-05

Locations